That's true.
Bristol own both Yervoy and Opdivo though so will be interesting to see how much support Yervoy continues to get a few years from now.
No doubt great results in combo with Yervoy will get interest from pharma especially with the preclinical pointing to efficacy wih PD1 drugs aswell.
Didn't stop me buying, just a bit unsure about that decision.